IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.32
+0.06 (+1.41%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,096.8% upside
Low Target
$40.79
Average Target
$51.70
High Target
$62.56
Current Price
$4.32
Current
$4.32
$4.32
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Scenario Analysis
Bear Case
$40.79
844.2%
Low target
Base Case
$51.70
+1,096.8%
Avg target
Bull Case
$62.56
+1,348.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$5.78
-25.3% from high
52-Week Low
$0.80
+440.0% from low
Target vs 52W High
$51.70
+794.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |